PyInvesting

Market research

002107.SHE Shandong Wohua Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

5.34 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
3B
P/E ratio
27.23
Analyst target
Not available
Dividend yield
4.3%
Beta
0.42

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Shandong Wohua Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 6.0% below its 200 day moving average.

From a valuation standpoint, the stock is 51.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.

Shandong Wohua Pharmaceutical Co., Ltd's total revenue rose by 15.8% to $252M since the same quarter in the previous year.

Its net income has increased by 15.2% to $51M since the same quarter in the previous year.

Finally, its free cash flow grew by 62.7% to $74M since the same quarter in the previous year.

Based on the above factors, Shandong Wohua Pharmaceutical Co., Ltd gets an overall score of 4/5.